Eculizumab in a patient with dense-deposit disease

N Engl J Med. 2012 Mar 22;366(12):1161-3. doi: 10.1056/NEJMc1112273.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Complement C5 / antagonists & inhibitors
  • Complement C5 / genetics
  • Complement C5 / immunology
  • Complement Membrane Attack Complex / analysis
  • Complement Membrane Attack Complex / antagonists & inhibitors*
  • Creatinine / blood
  • Female
  • Glomerulonephritis, Membranoproliferative / blood
  • Glomerulonephritis, Membranoproliferative / drug therapy*
  • Glomerulonephritis, Membranoproliferative / genetics
  • Humans
  • Rituximab

Substances

  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Complement C5
  • Complement Membrane Attack Complex
  • Rituximab
  • eculizumab
  • Creatinine